Related references
Note: Only part of the references are listed.Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS
Derek Yu et al.
GUT (2011)
Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: Frequency and predictors
Sanjeev Sachdeva et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation.
Mark Pimentel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
Savio C. Reddymasu et al.
BMC GASTROENTEROLOGY (2010)
Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia
Alexander C. Ford et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Irritable Bowel Syndrome and Small Intestinal Bacterial Overgrowth
David Yamini et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece
Panagiotis Katsinelos et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2009)
Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: Experience with Rifaximin
Sergio Peralta et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Bacterial Overgrowth and Irritable Bowel Syndrome: Unifying Hypothesis or a Spurious Consequence of Proton Pump Inhibitors?
Brennan M. R. Spiegel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Prevalence of cardiovascular risk factors and the metabolic syndrome in middle-aged men and women in Gothenburg, Sweden
Lennart Welin et al.
BMC PUBLIC HEALTH (2008)
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Iris Posserud et al.
GUT (2007)
High dosage rifaximin for the treatment of small intestinal bacterial overgrowth
E. Scarpellini et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management
Eamonn M. M. Quigley
JOURNAL OF DIGESTIVE DISEASES (2007)
Bacterial overgrowth as a cause of irritable bowel syndrome
Stephen M. Riordan et al.
CURRENT OPINION IN GASTROENTEROLOGY (2006)
The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome - A randomized trial
Mark Pimentel et al.
ANNALS OF INTERNAL MEDICINE (2006)
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence
AI Sharara et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome
A Lupascu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth
EC Lauritano et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth
G Nucera et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
The pathogenesis of gastrointestinal bacterial overgrowth
E Husebye
CHEMOTHERAPY (2005)
Tropical sprue is associated with contamination of small bowel with aerobic bacteria and reversible prolongation of orocecal transit time
UC Ghoshal et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Diagnosis of irritable bowel syndrome
KW Olden
GASTROENTEROLOGY (2002)
Share Paper
